These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 25723165)

  • 21. The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding.
    King LB; Fusco ML; Flyak AI; Ilinykh PA; Huang K; Gunn B; Kirchdoerfer RN; Hastie KM; Sangha AK; Meiler J; Alter G; Bukreyev A; Crowe JE; Saphire EO
    Cell Host Microbe; 2018 Jan; 23(1):101-109.e4. PubMed ID: 29324225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses.
    Wec AZ; Herbert AS; Murin CD; Nyakatura EK; Abelson DM; Fels JM; He S; James RM; de La Vega MA; Zhu W; Bakken RR; Goodwin E; Turner HL; Jangra RK; Zeitlin L; Qiu X; Lai JR; Walker LM; Ward AB; Dye JM; Chandran K; Bornholdt ZA
    Cell; 2017 May; 169(5):878-890.e15. PubMed ID: 28525755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the ebola virus envelope glycoprotein.
    Koellhoffer JF; Chen G; Sandesara RG; Bale S; Saphire EO; Chandran K; Sidhu SS; Lai JR
    Chembiochem; 2012 Nov; 13(17):2549-57. PubMed ID: 23111988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toremifene interacts with and destabilizes the Ebola virus glycoprotein.
    Zhao Y; Ren J; Harlos K; Jones DM; Zeltina A; Bowden TA; Padilla-Parra S; Fry EE; Stuart DI
    Nature; 2016 Jul; 535(7610):169-172. PubMed ID: 27362232
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human Survivors of Disease Outbreaks Caused by Ebola or Marburg Virus Exhibit Cross-Reactive and Long-Lived Antibody Responses.
    Natesan M; Jensen SM; Keasey SL; Kamata T; Kuehne AI; Stonier SW; Lutwama JJ; Lobel L; Dye JM; Ulrich RG
    Clin Vaccine Immunol; 2016 Aug; 23(8):717-24. PubMed ID: 27335383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural basis for differential neutralization of ebolaviruses.
    Bale S; Dias JM; Fusco ML; Hashiguchi T; Wong AC; Liu T; Keuhne AI; Li S; Woods VL; Chandran K; Dye JM; Saphire EO
    Viruses; 2012 Apr; 4(4):447-70. PubMed ID: 22590681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it.
    Lee JE; Saphire EO
    Curr Opin Struct Biol; 2009 Aug; 19(4):408-17. PubMed ID: 19559599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies.
    Ilinykh PA; Shen X; Flyak AI; Kuzmina N; Ksiazek TG; Crowe JE; Bukreyev A
    J Virol; 2016 Apr; 90(8):3890-3901. PubMed ID: 26819310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crystal Structure of the Marburg Virus Nucleoprotein Core Domain Chaperoned by a VP35 Peptide Reveals a Conserved Drug Target for Filovirus.
    Zhu T; Song H; Peng R; Shi Y; Qi J; Gao GF
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28659479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of the monoclonal antibodies composing ZMAb: a protective cocktail against Ebola virus.
    Audet J; Wong G; Wang H; Lu G; Gao GF; Kobinger G; Qiu X
    Sci Rep; 2014 Nov; 4():6881. PubMed ID: 25375093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and evaluation of bi- and trispecific antibodies targeting multiple filovirus glycoproteins.
    Nyakatura EK; Zak SE; Wec AZ; Hofmann D; Shulenin S; Bakken RR; Aman MJ; Chandran K; Dye JM; Lai JR
    J Biol Chem; 2018 Apr; 293(16):6201-6211. PubMed ID: 29500195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel MARV glycoprotein-specific antibody with potentials of broad-spectrum neutralization to filovirus.
    Zhang Y; Zhang M; Wu H; Wang X; Zheng H; Feng J; Wang J; Luo L; Xiao H; Qiao C; Li X; Zheng Y; Huang W; Wang Y; Wang Y; Shi Y; Feng J; Chen G
    Elife; 2024 Mar; 12():. PubMed ID: 38526940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural and molecular basis for Ebola virus neutralization by protective human antibodies.
    Misasi J; Gilman MS; Kanekiyo M; Gui M; Cagigi A; Mulangu S; Corti D; Ledgerwood JE; Lanzavecchia A; Cunningham J; Muyembe-Tamfun JJ; Baxa U; Graham BS; Xiang Y; Sullivan NJ; McLellan JS
    Science; 2016 Mar; 351(6279):1343-6. PubMed ID: 26917592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural and Functional Characterization of a Cross-Reactive Dengue Virus Neutralizing Antibody that Recognizes a Cryptic Epitope.
    Li J; Watterson D; Chang CW; Che XY; Li XQ; Ericsson DJ; Qiu LW; Cai JP; Chen J; Fry SR; Cheung STM; Cooper MA; Young PR; Kobe B
    Structure; 2018 Jan; 26(1):51-59.e4. PubMed ID: 29249606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel mutations in Marburg virus glycoprotein associated with viral evasion from antibody mediated immune pressure.
    Kajihara M; Nakayama E; Marzi A; Igarashi M; Feldmann H; Takada A
    J Gen Virol; 2013 Apr; 94(Pt 4):876-883. PubMed ID: 23288419
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine-elicited receptor-binding site antibodies neutralize two New World hemorrhagic fever arenaviruses.
    Clark LE; Mahmutovic S; Raymond DD; Dilanyan T; Koma T; Manning JT; Shankar S; Levis SC; Briggiler AM; Enria DA; Wucherpfennig KW; Paessler S; Abraham J
    Nat Commun; 2018 May; 9(1):1884. PubMed ID: 29760382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isolation of potent neutralizing antibodies from a survivor of the 2014 Ebola virus outbreak.
    Bornholdt ZA; Turner HL; Murin CD; Li W; Sok D; Souders CA; Piper AE; Goff A; Shamblin JD; Wollen SE; Sprague TR; Fusco ML; Pommert KB; Cavacini LA; Smith HL; Klempner M; Reimann KA; Krauland E; Gerngross TU; Wittrup KD; Saphire EO; Burton DR; Glass PJ; Ward AB; Walker LM
    Science; 2016 Mar; 351(6277):1078-83. PubMed ID: 26912366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus.
    Kuroda M; Fujikura D; Nanbo A; Marzi A; Noyori O; Kajihara M; Maruyama J; Matsuno K; Miyamoto H; Yoshida R; Feldmann H; Takada A
    J Virol; 2015 Jun; 89(12):6481-93. PubMed ID: 25855742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural Basis of Pan-Ebolavirus Neutralization by a Human Antibody against a Conserved, yet Cryptic Epitope.
    West BR; Moyer CL; King LB; Fusco ML; Milligan JC; Hui S; Saphire EO
    mBio; 2018 Sep; 9(5):. PubMed ID: 30206174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ebola Viral Glycoprotein Bound to Its Endosomal Receptor Niemann-Pick C1.
    Wang H; Shi Y; Song J; Qi J; Lu G; Yan J; Gao GF
    Cell; 2016 Jan; 164(1-2):258-268. PubMed ID: 26771495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.